文献速递新发突发、热带与寄生虫病

法国输入性重症恶性疟:青蒿琥酯与奎宁倾向评分分析

Propensity Score Analysis of Artesunate Versus Quinine for Severe Imported Plasmodium falciparum Malaria in France.
PubMed 文献 · Clin Infect Dis · 2020-01-01

该研究分析2011至2017年法国国家参考中心报告的所有重症输入性疟疾患者队列,采用逆概率治疗加权法控制混杂后比较奎宁与青蒿琥酯的28天死亡率及出院率。共纳入1544例,奎宁组460例死亡18例(3.9%),青蒿琥酯组1084例死亡32例(2.9%),两组死亡率(HR 1.03,95%CI 0.47-2.25)和出院率(HR 1.12,95%CI 0.94-1.34)无差异,但青蒿琥酯与更快的ICU出院率相关(HR 1.18,95%CI 1.02-1.36)。

要点

  • 重症输入性疟疾中青蒿琥酯与奎宁的28天死亡率无显著差异。
  • 青蒿琥酯组ICU出院更快(HR 1.18,95%CI 1.02-1.36)。
  • 两组住院出院率无差异(HR 1.12,95%CI 0.94-1.34)。

核心结论

  • 在高医疗水平国家,青蒿琥酯与更短的ICU住院时间相关,支持当前治疗转变,但死亡率或住院出院率与奎宁无差异。

研究设计与样本

  • 分析2011至2017年法国国家参考中心报告的所有重症输入性疟疾患者队列,共纳入1544例。
  • 采用逆概率治疗加权法控制奎宁组与青蒿琥酯组间差异,使用Kaplan-Meier估计和加权Cox比例风险模型比较28天死亡率及出院率。

主要发现

  • 奎宁组460例中死亡18例(3.9%),青蒿琥酯组1084例中死亡32例(2.9%)。
  • 奎宁与青蒿琥酯在死亡率上无差异,HR为1.03(95%CI 0.47-2.25)。
  • 两组住院出院率无差异,HR为1.12(95%CI 0.94-1.34)。
  • 青蒿琥酯与更快的ICU出院率相关,HR为1.18(95%CI 1.02-1.36)。

临床怎么用

  • 在医疗水平较高的非流行国家,重症输入性恶性疟可优先考虑青蒿琥酯以缩短ICU住院时间。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Little is known on the use of artesunate compared with quinine for the treatment of imported malaria cases in nonendemic countries with a high level of care. Therefore, we compared the 2 treatments in terms of mortality and hospital and intensive care unit (ICU) discharge rates. METHODS: We analyzed the cohort of all severe imported malaria patients reported to the French National Reference Center from 2011 to 2017. After controlling for differences between quinine- and artesunate-treated individuals using the inverse probability of treatment weighting method, 28-day mortality rate was compared between the groups as well as hospital and ICU discharge rates using Kaplan-Meier estimation and weighted Cox proportional hazard models. RESULTS: Overall, 1544 patients were enrolled. Fifty patients died, 18 in the quinine group (n = 460) and 32 in the artesunate group (n = 1084), corresponding to death rates of 3.9% and 2.9%, respectively. No difference was evident between quinine and artesunate either in mortality or in hospital discharge rate, with hazard ratios (HRs) of 1.03 (95% confidence interval [CI], 0.47-2.25) and 1.12 (95% CI, 0.94-1.34), respectively. Artesunate was associated with a faster ICU discharge rate (HR, 1.18. 95% CI, 1.02-1.36). CONCLUSIONS: In a country with a high level of care, artesunate was associated with a shorter length of stay in the ICU, which supports the actual therapeutic transition; however, no difference was found in terms of mortality or in hospital discharge rates between artesunate- and quinine-treated patients.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. El Ket N, Kendjo E, Thellier M, et al. Propensity Score Analysis of Artesunate Versus Quinine for Severe Imported Plasmodium falciparum Malaria in France. Clin Infect Dis. 2020. PMID: 30874798. doi:10.1093/cid/ciz206

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。